Dr. Gordon’s Comments:

Everything  you think you know about vitamin C is probably more than 50% wrong  and, if you relied on this official appearing document re vitamin C, you would not use it.  The attached document is from NIH so it gives you all the negative but you must know all that too.

But I am providing you with the contrary opinion. You will be amazed at how the right hand of the government does not know what the left hand is doing! FDA has approved vitamin C for treating one type of cancer!  That opens the door to great speculation and further research about non-toxic cancer therapies and I am excited to incorporate into this program the power of PEMF, which makes each cell ALKALINE and restores transmembrane potential. So I believe I have two or more non-toxic approaches that need to be looked at concurrently and incorporated with my FIGHT program for long term success.

Using IV VIT C with  my FIGHT program and PEMF ( Pulsed Electromagnetic  Field Therapy )  you will see and feel results  with PEMF on top of my FIGHT program, I am clearly  getting younger!

There are other ways to enhance the effectiveness of high dose IV Vitamin C in treating cancer and using it alone I do not find that IV VIT C is very often curative but it almost always helps and buys time for other therapies to be instituted.

Remember   we all need to improve outcomes, as our patients pay cash. We are not endowed by Government funds like our brethren using their chemo/radiation.  They are generally covered and   just bill the system and are ok no matter what the outcome.  We are NOT OK unless we turn out superior results and have data that shows we can beat mainstream outcomes hands down.

This NIH authoritative appearing well– referenced document would make anyone think oral low dose (2000 mg and under) Vitamin C is dangerous and causes cancer and heart disease. It appears to be fully referenced up to date through November 2009 yet it is missing an important point; somehow IV vitamin C WITH K-3 is now FDA approved for treating bladder cancer!! After all if anyone knew that vitamin C could be FDA approved for one cancer then some doctors would have some interest in trying it in other cancers just like the oncologists do everyday.

How can I and many of our colleagues be successfully using oral and IV vitamin C to keep Cancer patients alive far longer than their oncologists predict and still be considered by mainstream oncologists to be so wrong?  They tell their patients to never use vitamin C!

This report even has recommendations about not exceeding what they have established now, as their safe upper limit of oral vitamin C at 2000 mg MAX. Yet it is hard for them to ignore entirely what we are doing with cancer so they throw in some words to try to sound plausible with their otherwise very negative review of vitamin C. This is BURIED in the attached report but of course they have their numbers about what the maximum serum levels achievable with oral vitamin c vs.  the high serum levels achievable with IV Vitamin C. Those that are interested to get to the bottom of this mystery will find that vitamin c deserves your serious attention, IV and ORAL because there is always the rest of the story.

This is just one paragraph from many articles you may want to review once you read my comments: ’The bottom line is: Apatone selectively targets and kills tumor cells using non-toxic biochemistry that protects surrounding healthy tissue.” Licensed in 2004 to IC-MedTech, Inc., a California-based biotechnology company, the first clinical trial began in 2005 to evaluate the drug in prostate cancer patients. The clinical studies, which were conducted at Summa Health System in Akron, Ohio and with Dr. Ananias Diokno at William Beaumont Hospital in Royal Oak, Mich., examined the safety and effectiveness in 17 end-stage prostate cancer patients for 12 weeks. These patients took Apatone orally each day. The trials were supported by the Beaumont Foundation, Summa Health System and IC-MedTech.

Yet this is the best that the NIH report can offer the informed patients and physicians trying to help cancer patients. They admit there could be some discrepancy in the research but clearly tell no one that vitamin C is working when mixed with the correct form of vitamin K-3 (Apatone), which increases its oxidative capacity.

Remember this  work using vitamin C  for cancer  goes back several years now  and it consists IV vitamin C with the correct form of vitamin K, which unfortunately it appears that  most physicians  have never found  the correct form since there appears to be as many as 6 molecules being sold as vitamin K-3 and some are toxic. Yet in the lecture I will deliver for The Oxidative Training Workshop during IMOSAIC on April 7th at the Minneapolis conference, sponsored by ACAM, AHIMA, AAEM and ICIM, I will educate you about how easily you can kill the therapeutic effect when you are trying to master oxidative therapies with something as simple as giving NAC or GLUTATHIONE concurrently.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/

Excerpt:

Introduction
Vitamin C, also known as L-ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are unable to synthesize vitamin C endogenously, so it is an essential dietary component [1].

Vitamin C is required for the biosynthesis of collagen, L-carnitine, and certain neurotransmitters; vitamin C is also involved in protein metabolism [1,2]. Collagen is an essential component of connective tissue, which plays a vital role in wound healing. Vitamin C is also an important physiological antioxidant [3] and has been shown to regenerate other antioxidants within the body, including alpha-tocopherol (vitamin E) [4]. Ongoing research is examining whether vitamin C, by limiting the damaging effects of free radicals through its antioxidant activity, might help prevent or delay the development of certain cancers, cardiovascular disease, and other diseases in which oxidative stress plays a causal role. In addition to its biosynthetic and antioxidant functions, vitamin C plays an important role in immune function [4] and improves the absorption of nonheme iron [5], the form of iron present in plant-based foods. Insufficient vitamin C intake causes scurvy, which is characterized by fatigue or lassitude, widespread connective tissue weakness, and capillary fragility [1,2,4,6-9].

 Members and Friends
The courage the Jemsek family has shown facing life’s hurdles has given us a example of how to deal with our own adversities.  As they face renewed challenges, it is time for us all to reach out and do what we can to support them in their hour of need.
 
Please read this letter from Dr. Jemsek to the Lyme Community.  While Lyme patients cannot be direct donors, we can ask our healthy friends, family members and neighbors to consider this humanitarian request for a fine family that needs our support.  Please recirculate this message widely and as quickly as possible. 
 
Thank you,
NatCapLyme
 
Dear patients, friends, and family,

          My wife Kay and I are writing to you today to make a somber request on behalf of our six year old daughter, Jordan.  As most of you may already know, last September 2009 Jordan was diagnosed with acute myelogenous leukemia (AML). She received outstanding  care during several rounds of extended chemotherapy while hospitalized for 6 ½ months at Presbyterian Hospital in Charlotte at the Hemby Cancer center.  When Jordan was declared in remission  we were finally able to bring  her home on Easter day this Spring.  After several joyful months at home with Jordan, this past week we were devastated to learn that Jordan has relapsed. In the upcoming weeks, she will begin receiving chemotherapy in preparation for a bone marrow transplant that she will have later this winter.

          Last year, after much research aided by the excellent support of the Hemby physicians in Charlotte and the Pediatric Oncology Department at Children’s Hospital in Washington, DC,  we were already exploring the option for Jordan to have a bone marrow transplant in the event that the chemotherapy was ineffective.  Unfortunately, neither members of her family, nor those in the national donor registry provided a satisfactory match.  Unfortunately, at this time we are left without another option and must proceed with a bone marrow transplant for Jordan to survive.  We anticipate that the transplant will occur in March/April 2011 at Children’s Hospital in DC after Jordan undergoes an estimated 3 months of induction chemotherapy at the Hemby Center; she is on her way to the hospital with us today.   In order to increase the likelihood that we find a better match for Jordan, we are asking friends and family to participate in joining the National Marrow Donor Program. Because patients are most likely to match someone of their own race or ethnicity, please be aware that Jordan comes from a Scottish, Irish, and Ukrainian background. We have outlined the simple steps below in how one can get signed up to be part of this registry.

          For all of our patients and others suffering from  Lyme Borreliosis Complex, the highly disturbing irony is that the National Marrow Donor Program (NMDP) does recognize chronic Lyme disease while the general community does not. As part of the NMDP medical guidelines, patients with  ‘chronic Lyme disease ‘ may not register (details on the linked site below).  However, we would humbly request that those individuals struggling with Lyme Borreliosis encourage other family members and friends to consider joining the registry.

          As for those of you wanting to be tested specifically as a match for Jordan, i.e. a designated donation, due to the complicated process and cost of being tested privately, we instead recommend and request that you enter the general registry. We greatly appreciate all of the prayers and overwhelming support that our family has received, and we ask for you all to continue to pray as we continue on our journey towards Jordan’s recovery from this devastating disease. If you have questions, please contact Elizabeth Ballas at mailto:eballas@jemsekspecialty.com?subject=Jordan Jemsek.   As before, regular updates will be posted to http://www.caringbridge.org/ under keyword jordanjemsek.
 
God Bless,

Dr. and Mrs. Joseph G. Jemsek 
 
From the National Marrow Donor Program website:
 
In order to get signed up in the Be the Match Registry, please follow these easy steps.
 
1. To get signed up now, you can register online and have a test kit sent to your home!
    • Go to this website and follow the instructions: http://www.marrow.org/JOIN/Join_Now/join_now.html
 
              o Confirm you meet basic registry guidelines. (Must be between the ages of 18 and 60. Please pay special attention to the medical guidelines)
              o Complete the online form and order your registration kit, which should arrive in 7-10 days. It is free to join and get tested, but please also consider making a financial contribution.
              o Follow your instructions in your kit to collect a swab of cheek cells and return the kit in the mail.

2. If you’d like to get tested in person, please use the following link to locate a nearby donor drive or recruitment center.
 •  http://www.marrow.org/JOIN/Join_in_Person/index.html
 
For more information, please visit: http://www.marrow.org.

Full article: http://abc.herbalgram.org/site/MessageViewer?em_id=10401.0&dlv_id=31941

Excerpt:

 (Austin, TX) At least several times per year an article is published in a medical journal that purports to provide health professionals and the public with useful information on the safety of herbs and herbal dietary supplements. Instead, what sometimes occurs is an article written by people with apparently little to no expertise in the subject area of herbal medicine and medicinal plant research and likewise apparently peer reviewed—if peer reviewed at all—by reviewers with little botanical knowledge or expertise. Yesterday, the Journal of the American College of Cardiology published such an article.¹

This particular article has so many flaws and errors that it is difficult to know where to begin to critically review it.

 

Excerpt:

The study “provides preliminary evidence that milk thistle may be a safe, effective, supportive-care agent,” the researchers concluded in an online report in Cancer.

“Milk thistle needs to be studied further, to see how effective it is for a longer course of treatment, and whether it works well in reducing liver inflammation in other types of cancers and with other types of chemotherapy,” Kelly said in a press release issued by the American Cancer Society, publisher of Cancer. “However, our results are promising as there are no substitute medications for treating liver toxicity.”

A Woman’s Undying Gift to Science

I put down Rebecca Skloot’s first book, “The Immortal Life of Henrietta Lacks,” more than once. Ten times, probably. Once to poke the fire. Once to silence a pinging BlackBerry. And eight times to chase my wife and assorted visitors around the house, to tell them I was holding one of the most graceful and moving nonfiction books I’ve read in a very long time.

A thorny and provocative book about cancer, racism, scientific ethics and crippling poverty, “The Immortal Life of Henrietta Lacks” also floods over you like a narrative dam break, as if someone had managed to distill and purify the more addictive qualities of “Erin Brockovich,” “Midnight in the Garden of Good and Evil” and “The Andromeda Strain.” More than 10 years in the making, it feels like the book Ms. Skloot was born to write. It signals the arrival of a raw but quite real talent.